Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000147

Chairperson & CEO sold 9,500 shares at an average $494.83 ($4,700,851)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-22 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-22 Sale : show line 2 in the form 10b5-1 −240 $489.61 $117,507 333,703 I
2026-09-22 Sale : show line 3 in the form 10b5-1 −424 $490.54 $207,988 333,279 I
2026-09-22 Sale : show line 4 in the form 10b5-1 −736 $491.45 $361,705 332,543 I
2026-09-22 Sale : show line 5 in the form 10b5-1 −628 $492.67 $309,395 331,915 I
2026-09-22 Sale : show line 6 in the form 10b5-1 −1,645 $493.70 $812,139 330,270 I
2026-09-22 Sale : show line 7 in the form 10b5-1 −1,337 $494.66 $661,358 328,933 I
2026-09-22 Sale : show line 8 in the form 10b5-1 −1,488 $495.77 $737,700 327,445 I
Open-market sales · 9,500 sh · avg $494.83 · $4,700,851

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-22 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option −9,500 385,410 I
Loading xslF345X06/primarydocument.xml…